Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|January 1, 2022
Maternal-Newborn Health System Changes and Outcomes in Ontario, Canada, During Wave 1 of the COVID-19 Pandemic-A Retrospective StudyNicole F Roberts, Ann E Sprague, Monica Taljaard, et al.
Fetal Diagnosis and Therapy|May 17, 2017
Noninvasive Prenatal Detection of Trisomy 21 by Targeted Semiconductor Sequencing: A Technical Feasibility StudyYanwei Xi, Aryan Arbabi, Amy J M McNaughton, et al.
JCI Insight|March 23, 2026
DNA delivered by lipid nanoparticles induces CD8+ T cell-dependent antitumor responses and enhances anti-PD-L1 therapySeoyun Yum, Alba Rodríguez-Garcia, Joan Castellsagué, et al.
Clinical Genetics|June 23, 2025
Diagnostic Utility of Exome Data Reanalysis After In Silico Multi-Gene Panels or Clinical Exome Testing for Patients With Epilepsy and Developmental Delay/Intellectual Disability: A Retrospective Cohort StudyAlexanne Cuillerier, Andrea Goodman, Chloe Lawrence, et al.
Nature Medicine|June 3, 2020
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodiesChristian Leborgne, Elena Barbon, Jeffrey M Alexander, et al.
American Journal of Medical Genetics. Part A|November 10, 2023
Molecular characterization of 13 patients with PIK3CA-related overgrowth spectrum using a targeted deep sequencing approachLeanne de Kock, Alexanne Cuillerier, Meredith Gillespie, et al.
Journal of Medical Genetics|May 9, 2015
The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical GeneticistsKym Boycott, Taila Hartley, Shelin Adam, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 19, 2026
KMT2A and KMT2B episignatures address diagnostic challenges associated with rare neurodevelopmental disordersZain Awamleh, Anthony Chen, Sanaa Choufani, et al.
Plos Biology|January 6, 2026
TDP-43-mediated alternative polyadenylation is associated with a reduction in VPS35 and VPS29 expression in frontotemporal dementiaVidhya Maheswari Jawahar, Yi Zeng, Ellen M Armour, et al.
Nature Communications|November 5, 2021
Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primatesHelena Costa-Verdera, Fanny Collaud, Christopher R Riling, et al.
Pageof 11